knowledge -WSS

knowledge

author：Wikipedia 2025-09-28 04:58:51 - browse：97

Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Faced with fears of OxyContin misuse, sales reps touted its safety

hotspot

explore

WSS

The history of OxyContin, told through Purdue Pharma documents

Listen: Your guide to Wegovy's blockbuster heart study

Some of the ways extreme heat will change life as we know it

Doctors' information doesn't help them choose wisely when sick

Faced with fears of OxyContin misuse, sales reps touted its safety

Senators start work on Medicare physician payment reform

focus

knowledge

leisure time

New air purifier tech could be key to improving indoor air quality

CDC overhauls leadership of center that led response to Covid

Alkermes shareholders re

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

United colonoscopy coverage change 'may cost lives,' doctors say

Private equity deals in Medicare Advantage declines

Affirmative action in medical school literally saved lives

Large hospital system sues Multiplan for low

Peter Hotez and the public health issue of online harassment

An innovative path out of biotech’s “valley of death”

knowledge

Key House Republican on health care plans exit from Congress

To avoid data mishandling cases, universities eye AI and other tools

Trump, Nauta plead not guilty to new classified docs charges but De Oliveira still not arraigned

CDC overhauls leadership of center that led response to Covid

GOP presidential candidates start declaring their loyalty

PhRMA lawsuit over Medicare drug price negotiation tossed

explore

hotspot

explore

leisure time